• Industry news
• Psychiatry

Shire and Sandoz Settle All Pending Litigation Concerning ADDERALL XR

13 Oct 2009 - Philadelphia, PA - October 13, 2009 - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that it has settled all pending litigation with Sandoz, Inc. ("Sandoz") in connection with Sandoz's Abbreviated New Drug Application ("ANDA") and its attempt to market generic versions of Shire's ADDERALL XR more

Biovail Provides Update on Pimavanserin Collaborative Development Program

TORONTO--Oct. 6, 2009-- Biovail Corporation (NYSE/TSX: BVF) today provided an update on its Phase III program with pimavanserin for Parkinson's disease psychosis (PDP), which is being pursued in collaboration with ACADIA Pharmaceuticals Inc. Following the announcement on September 1st of disappointing top-line results from the first Phase III PDP trial, Biovail and ACADIA remain committed to the successful development of pimavanserin and have established a development strategy that they believe... more

Seroquel XR and Seroquel Approved in Europe for Prevention of Recurrence of Bipolar Disorder

September 29, 2009 AstraZeneca announced today that once-daily SEROQUEL XR (quetiapine fumarate extended-release tablets) and SEROQUEL (quetiapine fumarate) have been approved under the European Mutual Recognition Procedure for the prevention of recurrence of bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment. more

Search the Pharmalicensing Industry news by keyword. Alternatively our advanced search allows you to query by category and therapeutic target.
Category	Therapeutic target
Deals and Alliances Development Financial Results Financings Intellectual Property Regulatory	Cardiovascular Dermatology Endocrine and Metabolic Gastroenterology Genitourinary Hematology Immunology and Allergy Infection Musculoskeletal Neurology Obstetrics and Gynecology Oncology Ophthalmology Psychiatry Pulmonary
To choose more then one item on the list hold CTRL button while selecting. To deselect items press CTRL button and deselect.

Most Viewed

Biovail Provides Update on Pimavanserin Collaborative Development Program

Shire and Sandoz Settle All Pending Litigation Concerning ADDERALL XR

Seroquel XR and Seroquel Approved in Europe for Prevention of Recurrence of Bipolar Disorder

Genomas Awarded $1.4 Million NIH SBIR Grant to Develop MRI+DNA Guided Biomarker System for Mental Illness